allergan attacking B&L

Discussion in 'Valeant Pharmaceuticals' started by Anonymous, Aug 5, 2014 at 10:13 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    total crap. B&L is alive, well and healthy and growing.
    allergan has no clue in eye care they dont even have surgical they spun it off, what do they know
     

  2. Anonymous

    Anonymous Guest



    No clue in eye care? Been in the business for 65 years! You look foolish with that statement!
     
  3. Anonymous

    Anonymous Guest

    LOL x LOL

    almost spilled my coffee
     
  4. Anonymous

    Anonymous Guest

    Looks like it's not just Ackman that doesn't know Allergans business!! Dufus!
     
  5. Anonymous

    Anonymous Guest

    Allergan has no clue about the industry for which they are the biggest revenue generator
     
  6. Anonymous

    Anonymous Guest




    And you do???? LOL
     
  7. Anonymous

    Anonymous Guest

    Yes we do and we have better more dedicated people than you
     
  8. Anonymous

    Anonymous Guest

    And we don't clutter this site with garbage posts from you
     
  9. Anonymous

    Anonymous Guest

    Who is you and who is we

    Allergan dominates eyecare and knows everything about this space, including but not limited to IMS data containing B&L products.

    B&L retroactively lowers 2013 numbers to make 2014 growth look better and takes 20+% price increases on amazing products like Besivance.
     
  10. Anonymous

    Anonymous Guest

    One word - Restasis. Besides, everyone I know from B&L is rooting for Allergan.
     
  11. Anonymous

    Anonymous Guest

    Awww, you don't know do you ... I mean, really... nobody has told you.

    you poor Lamb.
     
  12. Anonymous

    Anonymous Guest

    view from europe - allergan is resorting to "the offer is grossly undervalued". they seem to have given up attacking B&L performance.
     
  13. Anonymous

    Anonymous Guest

    Exactly. The industry knows B&L has some decent products, but their sales and marketing idiots don't know how to sell it. B&L's numbers might appear healthy on the surface, but a dig deeper reveals it's merely due to expectation manipulation and margin increases over last year. It most certainly is not because of volume increases (if in doubt, have a conversation with the directors and managers at the plant level - production is flat from last year to this year). Visit the marketing "brain trust" in California, and you'll quickly discover how incompetent they are.